Inventor · disambiguated record
Christopher A. Teleha
Also filed as: ROSSANO LUCIUS T · TELEHA CHRISTOPHER · TELEHA CHRISTOPHER A · TELEHA CHRISTOPHER ALLAN
36 granted patents·3 pending applications·314 citations·filing 1992–2016
97Inventor score
Files withJANSSEN PHARMACEUTICA NV13DU PONT MERCK PHARMA10BRISTOL MYERS SQUIBB PHARMA CO3FURIEX PHARMACEUTICALS INC3BRANUM SHAWN T2
Top patents by PatentIndex Score
39 records- 0193US7994206B2Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acidJANSSEN PHARMACEUTICA NV·Filed 2008·Granted Aug 9, 2011·18 cites·5 claims
- 0292US8859604B2Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acidFURIEX PHARMACEUTICALS INC·Filed 2014·Granted Oct 14, 2014·14 cites·1 claims
- 0392US8691860B2Crystals and process of making 5-({(2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(-4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acidFURIEX PHARMACEUTICALS INC·Filed 2013·Granted Apr 8, 2014·16 cites·9 claims
- 0491US8609865B2Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acidANZALONE LUIGI·Filed 2011·Granted Dec 17, 2013·14 cites·7 claims
- 0591US7829584B2Pyridines and pyridine N-oxides as modulators of thrombinJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Nov 9, 2010·12 cites·10 claims
- 0691US5296478A1-substituted oxindoles as cognition enhancersDU PONT MERCK PHARMA·Filed 1992·Granted Mar 22, 1994·39 cites·8 claims
- 0790US9364489B2Crystals and process of making 5-({[2-amino-3-(4-Carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acidFOREST TOSARA LTD·Filed 2015·Granted Jun 14, 2016·11 cites·32 claims
- 0890US9115091B2Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl—1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acidFURIEX PHARMACEUTICALS INC·Filed 2014·Granted Aug 25, 2015·11 cites·46 claims
- 0988US8809327B2Sulfonamides as TRPM8 modulatorsBRANUM SHAWN T·Filed 2012·Granted Aug 19, 2014·13 cites·5 claims
- 1088US8153682B2Sulfonamides as TRPM8 modulatorsBRANUM SHAWN T·Filed 2008·Granted Apr 10, 2012·16 cites·37 claims
- 1187US9789125B2Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acidALLERGAN HOLDINGS UNLIMITED COMPANY·Filed 2016·Granted Oct 17, 2017·4 cites·40 claims
- 1286US7262210B2Fluorinated pyridine N-oxide thrombin modulators and process for N-oxidation of nitrogen containing heteroarylsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Aug 28, 2007·9 cites·8 claims
- 1384US5594001APolycyclic systems, and derivatives thereof, as neurotransmitter release enhancers useful in the treatment of cognitive disordersDU PONT MERCK PHARMA·Filed 1994·Granted Jan 14, 1997·26 cites·51 claims
- 1480US7897781B2Cold menthol receptor-1 antagonistsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Mar 1, 2011·6 cites·39 claims
- 1580US6667332B2Efficient process for the preparation of a factor Xa inhibitorBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Dec 23, 2003·11 cites·35 claims
- 1679US9464055B2Quinoline derivatives useful as CB-1 inverse agonistsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Oct 11, 2016·3 cites·16 claims
- 1778US5955475AProcess for manufacturing paroxetine solid dispersionsENDO PHARMACEUTICALS INC·Filed 1997·Granted Sep 21, 1999·57 cites·27 claims
- 1875US9266835B2Quinoline derivatives useful as CB-1 inverse agonistsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Feb 23, 2016·2 cites·21 claims
- 1972US9303046B2Process for the preparation of heterocyclic ester derivativesJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 5, 2016·1 cites·6 claims
- 2071US6747158B2Efficient process for the preparation of a factor Xa inhibitorBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Jun 8, 2004·4 cites·25 claims
- 2160US9434711B2Sulfonamides as TRPM8 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Sep 6, 2016·0 cites·2 claims
- 2260US9150532B2Fused cyclopentyl antagonists of CCR2JANSSEN PHARMACEUTICA NV·Filed 2014·Granted Oct 6, 2015·0 cites·1 claims
- 2357US9090639B2Cold menthol receptor-1 antagonistsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jul 28, 2015·0 cites·6 claims
- 2456US6417394B2Specific salt forms of triphenylethylene derivatives as selective estrogen receptor modulatorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Jul 9, 2002·1 cites·21 claims
- 2556US5532249ADisubstituted polycyclic systems as cognition enhancersDU PONT MERCK PHARMA·Filed 1994·Granted Jul 2, 1996·5 cites·39 claims
- 2654US2004198787A1Efficient process for the preparation of a factor Xa inhibitorFiled 2004·Application pending·0 cites
- 2751US2016168170A1Process for the preparation of heterocyclic ester derivativesJANSSEN PHARMACEUTICA NV·Filed 2016·Application pending·0 cites
- 2850US8629281B2Cold menthol receptor-1 antagonistsCOLBURN RAYMOND W·Filed 2011·Granted Jan 14, 2014·0 cites·34 claims
- 2948US9056850B2Process for the preparation of compounds useful as inhibitors of SGLTFILLIERS WALTER FERDINAND MARIA·Filed 2009·Granted Jun 16, 2015·0 cites·31 claims
- 3048US8680278B2Enantioselective process for preparing a substituted alkanoic acidKINNEY WILLIAM A·Filed 2008·Granted Mar 25, 2014·0 cites·9 claims
- 3147US5750528ABlockade of neuronal m-channels as a therapeutic approach to the treatment of neurological diseaseDU PONT MERCK PHARMA·Filed 1995·Granted May 12, 1998·13 cites·7 claims
- 3246US5698559ADisubstituted polycyclic systems as cognition enhancersDU PONT MERCK PHARMA·Filed 1996·Granted Dec 16, 1997·3 cites·33 claims
- 3346US5308851ABispyridyl-containing heterocycles useful for treating cognitive disordersDU PONT MERCK PHARMA·Filed 1993·Granted May 3, 1994·2 cites·12 claims
- 3445US9029352B2Process for the preparation of C-FMS kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted May 12, 2015·0 cites·62 claims
- 3542US5990132APolycyclic systems, and derivatives thereof, as neurotransmitter release enhancers useful in the treatment of cognitive disordersDU PONT MERCK PHARMA·Filed 1996·Granted Nov 23, 1999·2 cites·24 claims
- 3642US5428035A1-substituted azaoxindoles and pharmaceutical compositionsDU PONT MERCK PHARMA·Filed 1994·Granted Jun 27, 1995·1 cites·8 claims
- 3735US2015232439A1Process for the preparation of c-fms kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2015·Application pending·0 cites
- 3834US5597916A1 substituted oxindoles and azaoxindolesDU PONT MERCK PHARMA·Filed 1996·Granted Jan 28, 1997·0 cites·16 claims
- 3934US5519132APyridine compoundsDU PONT MERCK PHARMA·Filed 1995·Granted May 21, 1996·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Christopher A. Teleha files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →